Associations Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants and Risk of Coronavirus Disease 2019 (COVID-19) Hospitalization Among Confirmed Cases in Washington State: A Retrospective Cohort Study

被引:31
作者
Paredes, Miguel, I [1 ,2 ]
Lunn, Stephanie M. [3 ]
Famulare, Michael [4 ]
Frisbie, Lauren A. [3 ]
Painter, Ian [3 ]
Burstein, Roy [4 ]
Roychoudhury, Pavitra [2 ,5 ]
Xie, Hong [5 ]
Bakhash, Shah A. Mohamed [5 ]
Perez, Ricardo [5 ]
Lukes, Maria [5 ]
Ellis, Sean [5 ]
Sathees, Saraswathi [5 ]
Mathias, Patrick C. [5 ]
Greninger, Alexander [2 ,5 ]
Starita, Lea M. [6 ,7 ]
Frazar, Chris D. [6 ]
Ryke, Erica [6 ]
Zhong, Weizhi [7 ]
Gamboa, Luis [7 ]
Threlkeld, Machiko [6 ]
Lee, Jover [2 ]
McDermot, Evan [7 ]
Truong, Melissa [7 ]
Nickerson, Deborah A. [6 ,7 ]
Bates, Daniel L. [8 ]
Hartman, Matthew E. [8 ,9 ]
Haugen, Eric [8 ]
Nguyen, Truong N. [8 ]
Richards, Joshua D. [8 ]
Rodriguez, Jacob L. [8 ]
Stamatoyannopoulos, John A. [8 ]
Thorland, Eric [8 ]
Melly, Geoff [3 ]
Dykema, Philip E. [3 ]
MacKellar, Drew C. [3 ]
Gray, Hannah K. [3 ]
Singh, Avi [3 ]
Peterson, JohnAric M. [3 ]
Russell, Denny [3 ]
Torres, Laura Marcela [3 ]
Lindquist, Scott [3 ]
Bedford, Trevor [1 ,2 ,6 ,10 ]
Allen, Krisandra J. [3 ]
Oltean, Hanna N. [3 ]
机构
[1] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA
[2] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA
[3] Washington State Dept Hlth, Shoreline, WA, Australia
[4] Bill & Melinda Gates Fdn, Inst Dis Modeling, Seattle, WA USA
[5] Univ Washington, Dept Lab Med & Pathol, Seattle, WA 98195 USA
[6] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA
[7] Brotman Baty Inst Precis Med, Seattle, WA USA
[8] Altius Inst Biomed Sci, Seattle, WA USA
[9] Swedish Med Ctr, Dept Cardiovasc Serv, Seattle, WA USA
[10] Howard Hughes Med Inst, Seattle, WA USA
基金
美国国家卫生研究院;
关键词
COVID-19; SARS-CoV-2; variants; hospitalization; vaccination;
D O I
10.1093/cid/ciac279
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background The coronavirus disease 2019 (COVID-19) pandemic is dominated by variant viruses; the resulting impact on disease severity remains unclear. Using a retrospective cohort study, we assessed the hospitalization risk following infection with 7 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. Methods Our study includes individuals with positive SARS-CoV-2 reverse transcription polymerase chain reaction (RT-PCR) in the Washington Disease Reporting System with available viral genome data, from 1 December 2020 to 14 January 2022. The analysis was restricted to cases with specimens collected through sentinel surveillance. Using a Cox proportional hazards model with mixed effects, we estimated hazard ratios (HR) for hospitalization risk following infection with a variant, adjusting for age, sex, calendar week, and vaccination. Results In total, 58 848 cases were sequenced through sentinel surveillance, of which 1705 (2.9%) were hospitalized due to COVID-19. Higher hospitalization risk was found for infections with Gamma (HR 3.20, 95% confidence interval [CI] 2.40-4.26), Beta (HR 2.85, 95% CI 1.56-5.23), Delta (HR 2.28 95% CI 1.56-3.34), or Alpha (HR 1.64, 95% CI 1.29-2.07) compared to infections with ancestral lineages; Omicron (HR 0.92, 95% CI .56-1.52) showed no significant difference in risk. Following Alpha, Gamma, or Delta infection, unvaccinated patients show higher hospitalization risk, while vaccinated patients show no significant difference in risk, both compared to unvaccinated, ancestral lineage cases. Hospitalization risk following Omicron infection is lower with vaccination. Conclusions Infection with Alpha, Gamma, or Delta results in a higher hospitalization risk, with vaccination attenuating that risk. Our findings support hospital preparedness, vaccination, and genomic surveillance. Hospitalization risk following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant remains unclear. We find a higher hospitalization risk in cases infected with Alpha, Beta, Gamma, and Delta, but not Omicron, with vaccination lowering risk. Our findings support hospital preparedness, vaccination, and genomic surveillance.
引用
收藏
页码:E536 / E544
页数:9
相关论文
共 50 条
[11]   Effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus (COVID-19) vaccination on male fertility [J].
Chen, Fei ;
Zhang, Yunfei ;
Zhang, Yingze ;
Li, Yuqi ;
Ma, Jiao ;
Qin, Yining ;
Deng, Shuwen ;
Zhang, Yuhan ;
Wang, Deyang ;
Wang, Haiying ;
Lin, Juan .
SEXUAL HEALTH, 2024, 21 (02)
[12]   Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19) [J].
Biyan Nathanael Harapan ;
Hyeon Joo Yoo .
Journal of Neurology, 2021, 268 :3059-3071
[13]   Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19) [J].
Harapan, Biyan Nathanael ;
Yoo, Hyeon Joo .
JOURNAL OF NEUROLOGY, 2021, 268 (09) :3059-3071
[14]   Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel [J].
Swift, Melanie D. ;
Breeher, Laura E. ;
Tande, Aaron J. ;
Tommaso, Christopher P. ;
Hainy, Caitlin M. ;
Chu, Haitao ;
Murad, M. Hassan ;
Berbari, Elie F. ;
Virk, Abinash .
CLINICAL INFECTIOUS DISEASES, 2021, 73 (06) :E1376-E1379
[15]   Detectable Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Human Breast Milk of a Mildly Symptomatic Patient With Coronavirus Disease 2019 (COVID-19) [J].
Tam, Patrick C. K. ;
Ly, Kathleen M. ;
Kernich, Max L. ;
Spurrier, Nicola ;
Lawrence, Diana ;
Gordon, David L. ;
Tucker, Emily C. .
CLINICAL INFECTIOUS DISEASES, 2021, 72 (01) :128-130
[16]   Impact of Convalescent Plasma Therapy on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Profile in Coronavirus Disease 2019 (COVID-19) Patients [J].
Tang, Juanjie ;
Grubbs, Gabrielle ;
Lee, Youri ;
Golding, Hana ;
Khurana, Surender .
CLINICAL INFECTIOUS DISEASES, 2022, 74 (02) :327-334
[17]   Infectious Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Virus in Symptomatic Coronavirus Disease 2019 (COVID-19) Outpatients: Host, Disease, and Viral Correlates [J].
Mollan, Katie R. ;
Eron, Joseph J. ;
Krajewski, Taylor J. ;
Painter, Wendy ;
Duke, Elizabeth R. ;
Morse, Caryn G. ;
Goecker, Erin A. ;
Premkumar, Lakshmanane ;
Wolfe, Cameron R. ;
Szewczyk, Laura J. ;
Alabanza, Paul L. ;
Loftis, Amy James ;
Degli-Angeli, Emily J. ;
Brown, Ariane J. ;
Dragavon, Joan A. ;
Won, John J. ;
Keys, Jessica ;
Hudgens, Michael G. ;
Fang, Lei ;
Wohl, David A. ;
Cohen, Myron S. ;
Baric, Ralph S. ;
Coombs, Robert W. ;
Sheahan, Timothy P. ;
Fischer, William A. .
CLINICAL INFECTIOUS DISEASES, 2022, 75 (01) :E1028-E1036
[18]   Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection [J].
Tali, Seyed Hamid Safiabadi ;
LeBlanc, Jason J. ;
Sadiq, Zubi ;
Oyewunmi, Oyejide Damilola ;
Camargo, Carolina ;
Nikpour, Bahareh ;
Armanfard, Narges ;
Sagan, Selena M. ;
Jahanshahi-Anbuhi, Sana .
CLINICAL MICROBIOLOGY REVIEWS, 2021, 34 (03)
[19]   Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19) – anatomic pathology perspective on current knowledge [J].
Sambit K. Mohanty ;
Abhishek Satapathy ;
Machita M. Naidu ;
Sanjay Mukhopadhyay ;
Shivani Sharma ;
Lisa M. Barton ;
Edana Stroberg ;
Eric J. Duval ;
Dinesh Pradhan ;
Alexandar Tzankov ;
Anil V. Parwani .
Diagnostic Pathology, 15
[20]   Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19) - anatomic pathology perspective on current knowledge [J].
Mohanty, Sambit K. ;
Satapathy, Abhishek ;
Naidu, Machita M. ;
Mukhopadhyay, Sanjay ;
Sharma, Shivani ;
Barton, Lisa M. ;
Stroberg, Edana ;
Duval, Eric J. ;
Pradhan, Dinesh ;
Tzankov, Alexandar ;
Parwani, Anil, V .
DIAGNOSTIC PATHOLOGY, 2020, 15 (01)